T.D. Williamson Announces Strategic Investment from Apollo Funds
TULSA, Okla., June 11, 2025 /PRNewswire/ -- T.D. Williamson ("TDW"), a global leader in pipeline infrastructure technology and services, announced today a strategic investment from funds managed by Apollo (NYSE: APO) (the "Apollo Funds"). SCF...
ImmVira Announces First Patient Dosed in a Multi-Regional Phase II Clinical Trial Evaluating MVR-T3011 Oncolytic Immunotherapy in Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
SUZHOU, China, June 10, 2025 /PRNewswire/ -- ImmVira, a global leading clinical-stage biotechnology company focused on the development of next-generation novel oncolytic immunotherapy for treatment of cancer, announced that the first patient...
Altair Announces ATCx AI for Engineers 2025 Global Virtual Event
Event will showcase AI-powered engineering, smart manufacturing, and scaling intelligence with HPC and AI TROY, Mich., June 10, 2025 /PRNewswire/ -- Altair, a global leader in computational intelligence, announced it will host ATCx AI for Engineers...
China Automotive Systems Announces Annual Meeting on June 25, 2025
2025 AGM will be held on Wednesday, June 25, 2025 at 9:00 AM local time, or 9:00 PM EDT on Tuesday, June 24, 2025 WUHAN, China, June 10, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power...
Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy
LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe, who progress rapidly to end-stage heart failure. NVC-001 demonstrated significant...
KIWI design Announces Limited-Time Discount on Best-Selling K4 Head Strap for Meta Quest 3/3S
LOS ANGELES, June 10, 2025 /PRNewswire/ -- KIWI design, a global leader in premium XR accessories, is excited to announce a limited-time offer on one of its most popular products – the K4 Comfort Head Strap. KIWI design K4 Comfort Head Strap 25% Off...
Abbisko Therapeutics Announces China NMPA Acceptance of New Drug Application for Pimicotinib for the Treatment of TGCT
SHANGHAI, June 10, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for pimicotinib, a highly selective,...
The Hashemite Kingdom of Jordan Announces New Ocean Innovation Hub in Partnership with Innovative Blue Technology Company Voyacy Regen
Located in the Gulf of Aqaba, in the Hashemite Kingdom of Jordan, the Aqaba Marine Park will focus on building climate-resilient coastal marine infrastructure at an unprecedented scale NICE, France, June 10, 2025 /PRNewswire/ -- Today, His Majesty...
Eluminex Biosciences Announces Phase 1b Single Ascending Dose Study Results of a Novel Pentavalent Trispecific Fusion Antibody (EB-105) in Patients with Diabetic Macular Edema (DME)
EB-105 Targets VEGF-A, -B, PlGF, Ang-2, and IL-6R Improvements in Visual Acuity and Retinal Edema Observed at All Dose Levels No Safety Issues Observed Following a Single Intravitreal (IVT) Injection Multiple Ascending Dose Study Planned for Q3 2025...
VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.
HONG KONG and WENZHOU, China, June 10, 2025 /PRNewswire/ -- VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today that it received written...